title: Community pharmacists' knowledge of and attitudes toward oral chemotherapy.
abstract: OBJECTIVE
  To assess community pharmacists' attitude toward and knowledge of oral chemotherapy (OC) in terms of drug indications, general dosing principles, drug interactions, adverse effects, and special handling precautions.
  
  
  METHODS
  Descriptive, nonexperimental, cross-sectional survey.
  
  
  METHODS
  Colorado, Kansas, and the southeastern United States in May and June 2005.
  
  
  METHODS
  1,080 pharmacists in four divisions of a large community pharmacy chain.
  
  
  METHODS
  Web-based survey.
  
  
  METHODS
  Pharmacist knowledge of and attitude toward OC.
  
  
  RESULTS
  243 surveys were returned (response rate 22.5%). Overall, pharmacists answered 49.7% of knowledge questions correctly. Pharmacists were most knowledgeable about general dosing principles (69%) and least knowledgeable about adverse effects (45%) and special handling (25%) of OC. Higher scores were seen for pharmacists who dispensed a greater number of OC prescriptions. Percentages of correct responses did not vary based on years of experience or number of OC continuing pharmacy education (CPE) programs attended. On a Likert-type scale of 1 (low) to 5 (high), the average comfort in dispensing OC was 2.4. On average, pharmacists indicated that knowing about OC was important to their practice (3.7) and expressed interest in participating in additional CPE programs on OC (4.2). Of respondents, 94.7% indicated that their pharmacy did not have a counting tray devoted to cytotoxic drugs.
  
  
  CONCLUSIONS
  This survey identified several areas in which pharmacists' knowledge of OC could be enhanced. Handling of OC is an area of important need, given the low number of pharmacists reporting separate counting trays for cytotoxic drugs.
authors.affiliation: School of Pharmacy, University of Colorado, Aurora, CO 80045, USA. cindy.obryant@ucdenver.edu
authors.forename: Cindy L
authors.initials: CL
authors.lastname: O'Bryant
authors.forename: Brian C
authors.initials: BC
authors.lastname: Crandell
mesh_terms: D000284:Administration, Oral; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D003157:Community Pharmacy Services / Q000458:organization & administration; D003430:Cross-Sectional Studies; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D004513:Education, Pharmacy, Continuing; D004864:Equipment and Supplies; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D016273:Occupational Exposure / Q000517:prevention & control; D010595:Pharmacists / Q000523:psychology*; D011795:Surveys and Questionnaires; D014481:United States
chemical_list: D000970:Antineoplastic Agents